Stephen Robert Gregory

All filings by Stephen Robert Gregory on record concern Acerus Pharmaceuticals Corporation. Over a trading history stretching from 22 March 2018 to 26 November 2020, the count stands at 11 filings.

The open-market record is one-sided, with 9 purchases worth €159k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

A typical purchase (the median) is worth €6,680. None of the 9 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The latest filing, published on 27 November 2020, reports a transaction of €50k in Acerus Pharmaceuticals Corporation. The last insider purchase was made public on 26 December 2018, 2,861 days ago. Typically, a trade is published a median of 1 day after it takes place. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.